Glucose challenge test screening for prediabetes and undiagnosed diabetes

Diabetologia

Volumn 52, Issue 9, 2009, Pages 1798-1807

  Phillips, L S ^a,b   Ziemer, D C ^a   Kolm, P ^c   Weintraub, W S ^c   Vaccarino, V ^a   Rhee, M K ^a   Chatterjee, R ^d,e   Narayan, K M V ^a,d   Koch, D D ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ATLANTA VA MEDICAL CENTER   (United States)

^c CHRISTIANA CARE HEALTH SYSTEM   (United States)

^d EMORY UNIVERSITY   (United States)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Glucose challenge; Natural history; Prediabetes; Preventive management; Screening; Type 2 diabetes

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

ADULT; AGED; ARTICLE; CAPILLARY BLOOD; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; SCREENING TEST;

ADOLESCENT; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; BLOOD GLUCOSE; COSTS AND COST ANALYSIS; DIABETES MELLITUS; DIABETES, GESTATIONAL; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GEORGIA; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PREDIABETIC STATE; PREGNANCY; YOUNG ADULT;

EID: 68449083812     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-009-1407-7     Document Type: Article

References (49)

1. JB Saaddine B Cadwell EW Gregg 2006 Improvements in diabetes processes of care and intermediate outcomes: United States, 1988-2002 Ann Intern Med 144 465 474
2. TJ Hoerger JE Segel EW Gregg JB Saaddine 2008 Is glycemic control improving in U.S. adults? Diabetes Care 31 81 86
3. P Absetz R Valve B Oldenburg 2007 Type 2 diabetes prevention in the "real world": one-year results of the GOAL implementation trial Diabetes Care 30 2465 2470
4. LS Phillips WT Branch Jr CB Cook 2001 Clinical inertia Ann Int Med 135 825 834
5. RR Holman 1998 Assessing the potential for alpha-glucosidase inhibitors in prediabetic states Diabetes Res Clin Pract 40 Suppl S21 S25
6. C Weyer C Bogardus DM Mott RE Pratley 1999 The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus J Clin Invest 104 787 794
7. AE Butler J Janson S Bonner-Weir R Ritzel RA Rizza PC Butler 2003 Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes Diabetes 52 102 110
8. GA Nichols CM Alexander CJ Girman SJ Kamal-Bahl JB Brown 2006 Treatment escalation and rise in HbA1c following successful initial metformin therapy Diabetes Care 29 504 509
9. TA Buchanan 2007 (How) can we prevent type 2 diabetes? Diabetes 56 1502 1507
10. X Pi-Sunyer G Blackburn FL Brancati 2007 Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial Diabetes Care 30 1374 1383
11. CC Cowie KF Rust ES Ford 2009 Full accounting of diabetes and pre-diabetes in the U.S. population in 1988-1994 and 2005-2006 Diabetes Care 32 287 294
12. National Centre for Chronic Disease Prevention and Health Promotion (2007) 2007 National diabetes fact sheet. Available from www.cdc.gov/diabetes/ pubs/factsheet07.htm, accessed 1 March 2008
13. MW Ealovega BP Tabaei M Brandle R Burke WH Herman 2004 Opportunistic screening for diabetes in routine clinical practice Diabetes Care 27 9 12
14. LA Leiter A Barr A Belanger 2001 Diabetes screening in Canada (DIASCAN) study: prevalence of undiagnosed diabetes and glucose intolerance in family physician offices Diabetes Care 24 1038 1043
15. SM Twigg MC Kamp TM Davis EK Neylon JR Flack 2007 Prediabetes: a position statement from the Australian Diabetes Society and Australian Diabetes Educators Association Med J Aust 186 461 465
16. The DECODE Study Group on behalf of the European Diabetes Epidemiology Group 1999 Glucose tolerance and mortality: comparison of WHO and American Diabetic Association diagnostic criteria Lancet 354 617 621
17. JB Meigs DM Nathan RB D'Agostino Jr PWF Wilson 2002 Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham Offspring Study Diabetes Care 25 1845 1850
18. JD Sorkin DC Muller JL Fleg R Andres 2005 The relation of fasting and 2-h postchallenge plasma glucose concentrations to mortality: data from the Baltimore Longitudinal Study of Aging with a critical review of the literature Diabetes Care 28 2626 2632
19. ER DeLong DM DeLong DL Clarke-Pearson 1988 Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach Biometrics 44 837 845
20. CDC Diabetes Cost-Effectiveness Study Group 1998 The cost-effectiveness of screening for type 2 diabetes JAMA 280 1757 1763
21. MB Schulze K Hoffmann H Boeing 2007 An accurate risk score based on anthropometric, dietary, and lifestyle factors to predict the development of type 2 diabetes Diabetes Care 30 510 515 (Pubitemid 46354326)
22. W Aekplakorn P Bunnag M Woodward 2006 A risk score for predicting incident diabetes in the Thai population Diabetes Care 29 1872 1877
23. KE Heikes DM Eddy B Arondekar L Schlessinger 2008 Diabetes Risk Calculator: a simple tool for detecting undiagnosed diabetes and pre-diabetes Diabetes Care 31 1040 1045
24. CD Saudek WH Herman DB Sacks RM Bergenstal D Edelman MB Davidson 2008 A new look at screening and diagnosing diabetes mellitus J Clin Endocrinol Metab 93 2447 2453
25. DR McCance RL Hanson M-A Charles 1994 Comparison of tests for glycated haemoglobin and fasting and two hour plasma glucose concentrations as diagnostic methods for diabetes BMJ 308 1323 1328
26. CL Rohlfing RR Little H-M Wiedmeyer 2000 Use of GHb (HbA1c) in screening for undiagnosed diabetes in the U.S. population Diabetes Care 23 187 191
27. AA Motala MAK Omar 1992 The value of glycosylated haemoglobin as a substitute for the oral glucose tolerance test in the detection of impaired glucose tolerance (IGT) Diab Res Clin Prac 17 199 207
28. E Kilpatrick PW Maylor BG Keevil 1998 Biological variation of glycated hemoglobin: implications for diabetes screening and monitoring Diabetes Care 21 261 264
29. SL Edelstein WC Knowler RP Bain 1997 Predictors of progression from impaired glucose tolerance to NIDDM: an analysis of six prospective studies Diabetes 46 701 710
30. E Mannucci G Bardini A Ognibene CM Rotella 1999 Comparison of ADA and WHO screening methods for diabetes mellitus in obese patients Diabetic Med 16 579 585
31. JI Barzilay CF Spiekerman PW Wahl 1999 Cardiovascular disease in older adults with glucose disorders: comparison of American Diabetes Association criteria for diabetes mellitus with WHO criteria Lancet 354 622 625
32. C-J Chang J-S Wu F-H Lu H-L Lee Y-C Yang M-J Wen 1998 Fasting plasma glucose in screening for diabetes in the Taiwanese population Diabetes Care 21 1856 1860
33. MI Schmidt BB Duncan A Vigo 2003 Detection of undiagnosed diabetes and other hyperglycemia states Diabetes Care 26 1338 1343
34. SL Johnson BP Tabaei WH Herman 2005 The efficacy and cost of alternative strategies for systematic screening for type 2 diabetes in the U.S. population 45-74 years of age Diabetes Care 28 307 311
35. P Zhang MM Engelgau R Valdez B Cadwell SM Benjamin KMV Narayan 2005 Efficient cutoff points for three screening tests for detecting undiagnosed diabetes and pre-diabetes: an economic analysis Diabetes Care 28 1321 1325
36. TJ Hoerger KA Hicks SW Sorensen 2007 Cost-effectiveness of screening for pre-diabetes among overweight and obese U.S. adults Diabetes Care 30 2874 2879
37. MA Abdul-Ghani K Williams RA Defronzo M Stern 2007 What is the best predictor of future type 2 diabetes? Diabetes Care 30 1544 1548
38. MA Abdul-Ghani T Abdul-Ghani N Ali RA Defronzo 2008 One-hour plasma glucose concentration and the metabolic syndrome identify subjects at high risk for future type 2 diabetes Diabetes Care 31 1650 1655
39. Chemistry/Therapeutic Drug Monitoring Survey (2008) College of American Pathologists (Northfield, IL, USA). Available from www.cap.org, accessed 15 May 2009
40. Y-W Park S Zhu L Palaniappan S Heshka MR Carnethon SB Heymsfield 2003 The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994 Arch Intern Med 163 427 436 (Pubitemid 36241019)
41. WH Herman M Brandle P Zhang The Diabetes Prevention Program Research Group 2003 Costs associated with the primary prevention of type 2 diabetes mellitus in the Diabetes Prevention Program Diabetes Care 26 36 47 (Pubitemid 36928992)
42. P Zhang MM Engelgau R Valdez SM Benjamin B Cadwell KMV Narayan 2003 Costs of screening for pre-diabetes among U.S. adults Diabetes Care 26 2536 2542
43. RJ Troisi CC Cowie MI Harris 2000 Diurnal variation in fasting plasma glucose: implications for diagnosis of diabetes in patients examined in the afternoon JAMA 284 3157 3159
44. KMV Narayan JP Boyle TJ Thompson SW Sorensen DF Williamson 2003 Lifetime risk for diabetes mellitus in the United States JAMA 290 1884 1890
45. LM Thaler IM El-Kebbi DC Ziemer DL Gallina VG Dunbar LS Phillips 1998 High prevalence of albuminuria among African-Americans with short duration of diabetes Diabetes Care 21 1576 1577
46. DM Erdman CB Cook KJ Greenlund 2002 The impact of outpatient diabetes management on serum lipids in urban African-Americans with type 2 diabetes Diabetes Care 25 9 15
47. S Keech D Colquehoun J Best 2003 Secondary prevention of cardiovascular events with long-term pravastatin in patients with diabetes or impaired fasting glucose: results from the LIPID trial Diabetes Care 26 2713 2721
48. WH Herman TJ Hoerger M Brandle 2005 The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance Ann Intern Med 142 323 332
49. American Diabetes Association, NIH/NIDDK 2002 The prevention or delay of type 2 diabetes Diabetes Care 25 742 749